Navigation Links
Metastatic Bone Disease Patients Can Walk in Lazarus' Footsteps
Date:3/9/2009

"Miraculous" Effects, Pain Relief of Osteoplasty -- an Interventional Radiology Treatment -- Detailed for Those Suffering From Cancer Spread

SAN DIEGO, March 9 /PRNewswire-USNewswire/ -- Osteoplasty -- a highly effective minimally invasive procedure to treat the painful effects of metastatic bone disease by injecting bone cement to support weakened bones -- provides immediate and substantial pain relief, often presenting individuals who are suffering terribly with the miraculous so-called "Lazarus effect," according to researchers at the Society of Interventional Radiology's 34th Annual Scientific Meeting. Interventional radiologists often couple osteoplasty with heat or cold treatments to kill tumor nerves, if needed.

"The immediate good clinical results observed in our patients should encourage more widespread application of this palliative interventional radiology treatment," said Giovanni C. Anselmetti, M.D., interventional radiologist at the Institute for Cancer Research and Treatment in Turin, Italy. "A patient's quality of life can be severely affected when they have metastatic bone disease. Normal daily activities can become difficult when the metastases become painful, and many patients report that their sleep patterns change, appetite diminishes and the need to take pain relief medications increases," he noted. "Osteoplasty is not a first-line treatment. It is a highly effective minimally invasive procedure that provides pain relief for patients not responding to conventional pain medication treatments," he said. "Metastatic bone disease patients -- who have no other options, who are in pain, who have short life expectancies and who have dismal quality of life -- should be referred to interventional radiologists for osteoplasty treatment. Interventional radiologists can improve the quality of life for patients who have very large metastases and who are going to die because of their primary cancers," added Anselmett
'/>"/>

SOURCE Society of Interventional Radiology
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine technology :

1. Oncolytics Biotech Inc. Announces Start of Patient Enrolment in Translational Clinical Trial Investigating REOLYSIN(R) in Patients with Metastatic Colorectal Cancer
2. Study Finds DOXIL(R) Combination Therapy Delays Disease Progression for Patients With Metastatic Breast Cancer
3. RAD001 Shows Potential to Reverse Resistance to Herceptin(R)* in Metastatic Breast Cancer Patients, Leading to Phase III Trial
4. Bionovo Presents Positive Results from Phase 1B Trial of BZL101 for Metastatic Breast Cancer at the Society for Integrative Oncology
5. Bionovo Advances BZL101 to Phase 2 Clinical Trials After Positive Phase 1 Results for Metastatic Breast Cancer
6. CuraGen Announces Preliminary Data from Ongoing Phase II Study Showing Clinical Activity of CR011-vcMMAE in Patients with Metastatic Melanoma
7. CuraGen Completes Enrollment in Phase II Trial of CR011-vcMMAE in Metastatic Melanoma
8. Cell Therapeutics Announces that the European Organization for Research and Treatment of Cancer Completes Enrollment in Phase II Clinical Trial of Brostallicin as First Line Therapy for Advanced or Metastatic Soft Tissue Sarcoma
9. Journal of Clinical Oncology Article Highlights CellSearch(TM) Circulating Tumor Cell Test in Treatment of Metastatic Colorectal Cancer
10. Rosetta Genomics and Collaborators Identify MicroRNAs That Can Accurately Discriminate Between Primary and Metastatic Tumors in the Brain
11. Results Published in the Journal Cancer Demonstrate that Oral Talactoferrin Alfa is Active as Monotherapy in Previously Treated Patients with Metastatic Renal Cell Carcinoma
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/6/2015)... July 6, 2015 E-QURE Corp (OTCQB: EQUR), ... live at VirtualInvestorConferences.com on July 9, 2015. ... http://tinyurl.com/e-qure-presentation This will be a ... ask the company questions in real-time - both in ... trade booth." If attendees are not able to join ...
(Date:7/6/2015)... July 6, 2015 Array BioPharma,s (NASDAQ: ... this past weekend at the 2015 ESMO World ... At the meeting, data were shared from a ... 100-patient randomized Phase 2 expansion of that trial ... EGFR inhibitor, with or without the addition of ...
(Date:7/6/2015)... FRANCISCO, Calif. , July 6, 2015 ... pharmaceutical company, and Oculeve, a development-stage medical device company ... today announced that they have entered into an agreement ... transaction.  Under the terms of the agreement, Allergan will ... commercialization milestone payments related to Oculeve,s lead development program ...
Breaking Medicine Technology:E-QURE Corp to Webcast, Live, at VirtualInvestorConferences.com July 9 2Encorafenib-Based Regimens Show Promising Clinical Activity In BRAF-Mutant Colorectal Cancer Patients 2Encorafenib-Based Regimens Show Promising Clinical Activity In BRAF-Mutant Colorectal Cancer Patients 3Encorafenib-Based Regimens Show Promising Clinical Activity In BRAF-Mutant Colorectal Cancer Patients 4Allergan to Acquire Oculeve Dry Eye Disease Development Programs 2Allergan to Acquire Oculeve Dry Eye Disease Development Programs 3Allergan to Acquire Oculeve Dry Eye Disease Development Programs 4
... Solutions, Inc. (OTCBB: BLFS), a leading developer and manufacturer ... tissues, today announced preliminary revenue of $611,000 for its ... sequential growth over the fourth quarter of 2010 and ...   (Logo:   http://photos.prnewswire.com/prnh/20090814/BIOLIFELOGO ) ...
... 2011 The American Center for Law and Justice (ACLJ), ... pro-life pharmacy owners in Illinois after a legal battle lasting ... decision striking down a state law that compels pharmacy owners ... even if doing so violates their religious or moral beliefs. ...
Cached Medicine Technology:BioLife Solutions Announces Record Quarterly Revenue 2BioLife Solutions Announces Record Quarterly Revenue 3BioLife Solutions Announces Record Quarterly Revenue 4ACLJ Gets Win for Pro-Life Pharmacy Owners in Illinois After Lengthy Legal Battle 2ACLJ Gets Win for Pro-Life Pharmacy Owners in Illinois After Lengthy Legal Battle 3
(Date:7/6/2015)... ... July 06, 2015 , ... World renowned Los ... to achieve their ideal appearance through comprehensive treatment solutions. Individuals that want to make ... doctor and receive a plan that resolves each of their needs. , "Anytime ...
(Date:7/6/2015)... VA (PRWEB) , ... July 06, 2015 , ... ... that Dr. Jeffrey R. Carlson finished his 100th case using SpineFrontier’s® PedFuse® REmind® ... Mary Immaculate Hospital in Newport News, VA. The procedure was an L5-S1 posterior ...
(Date:7/6/2015)... ... 2015 , ... The Path of Least Resistance: The Evolution of Capitalism and ... U.S. economy over the past 40 years. The book explores the evolution of the ... book is a time capsule that chronicles the economic development of the United States ...
(Date:7/5/2015)... ... , ... Women's Excellence in Wellness, powered by Movestrong announces parent/child ... geared towards families that want their children to stay active as well as spend ... will take place TUESDAYS at 4:30pm. Questions? Call 248-601-6683. Women’s Excellence in Wellness, ...
(Date:7/5/2015)... (PRWEB) , ... July 05, 2015 , ... Doctors at ... a new IMRT/surgery combination may one day change the outlook for people with pleural ... it now. , Researchers report that five mesothelioma patients treated with 25Gy ...
Breaking Medicine News(10 mins):Health News:Los Angeles Plastic Surgeon, Dr. Paul Nassif, is Now Offering Comprehensive Facial Plastic Surgery Procedures 2Health News:100th Outpatient Less Exposure Surgery Procedure Completed by Industry Leading Surgeon Dr. Jeffrey Carlson 2Health News:100th Outpatient Less Exposure Surgery Procedure Completed by Industry Leading Surgeon Dr. Jeffrey Carlson 3Health News:New Book Brings Reveals The Repercussions Associated With The Global Economy 2Health News:New Mesothelioma Study Calls IMRT/Surgery Combo “Innovative and Promising”, According to Surviving Mesothelioma 2
... Modest reduction may be worthwhile for those most at ... News) -- Children who are predisposed to recurrent urinary ... a new Australian study suggests that such prophylactic therapy ... Only 13 percent of youngsters who were given the ...
... ... State Long Term Care Ombudsman, Speaks at Gladys B. Jacobs Manor, in North Central ... Philadelphia, ... Term Care Ombudsman, the first Latina ever appointed to that position, recently spoke at ...
... In response to rising suicide and divorce rates within ... marriages and families, will present its Weekend to Remember® ... in Vancouver, Wash. from Nov. 6 - 8 at the ... Ore. from Nov. 20 - 22 at the Red Lion ...
... JACKSONVILLE, Fla., Oct. 28 Blue Cross and Blue Shield ... Echo Gold Award for the Power of the ... from worldwide companies, the competition honors the best direct marketing ... presented at the 2009 international awards ceremony in San Diego ...
... Oct. 28 If we get a boo-boo, we might know ... mom kiss it and make it all better. But, what ... of us who aren,t prepared for dental emergencies can quickly get ... Drug Company at: , http://inr.mediaseed.tv/oneClip_C/?feed=Ss8P5Rb1iQulYDAELUR0M_kpwKp_6YSM , ...
... voice on the telephone line when you fear you,ve had ... questions about the H1N1 flu pandemic. , The nation,s 60 ... to H1N1, with states putting their poison centers to work ... Florida,s three poison control centers have been assisting the ...
Cached Medicine News:Health News:Preventive Antibiotics Help Some Kids Fend Off Urinary Infections 2Health News:Preventive Antibiotics Help Some Kids Fend Off Urinary Infections 3Health News:Head of PA Department of Aging Speaks at the Richard Allen Committee's 17th Annual Senior Citizen's Event 2Health News:FamilyLife Supports Military Marriages in Portland Area 2Health News:Blue Cross and Blue Shield of Florida's Power of the Human Voice Campaign Wins Prestigious DMA International ECHO Gold Award 2Health News:American Association of Poison Control Centers: Count U.S. Poison Centers Among First Responders in H1N1 Flu Pandemic 2
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
Medicine Products: